ArticleGene therapy2003
In vivo adenovirus-mediated delivery of a uPA/uPAR antagonist reduces retinal neovascularization in a mouse model of retinopathy.
L Le Gat et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this paperpooled itcites it